Natco Pharma

Activities: Pharmaceutical

Trending Articles

  1. Navin Molecular constructs a new R&D facility in Dewas, India The laboratory will enhance the CDMO's small molecule laboratory- and kilo-scale process development capabilities, as well as its analytical development and testing capacity
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    The ABCs of ADCs: manufacturing ultra-high potent active ingredients Senior Technical Manager at Sterling Pharma Solutions, Matt Miklas, presents a pragmatic approach to the safe and cost-effective production of highly potent pharmaceutical...
  3. Pharmapack predicts how the pharmaceutical market will operate in 2025 Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025
  4. Servier expands AI partnership with Google Cloud to bolster pharma R&D efforts The company will utilise AI and generative AI technology to optimise its therapeutic target/drug discovery and development processes
  5. Cytiva and Cellular Origins team up to advance the cell and gene therapy manufacturing process By combining Cytiva's Sefia platform with Cellular Origins' automated Constellation platform, the two will help its customers to efficiently scale up CGT production to...

Upcoming event

Pharmapack

22 – 23 January 2025 | Exhibition | Paris, France See all

Related Content

Regulatory

Several large Indian pharma companies under US FDA scrutiny

Recent regulatory action by the FDA on leading Indian firms has affected the country's exports, according to Chairman of Dr. Reddy's Laboratories
Finance

Natco shows there is more to Indian pharma than generics

Company is establishing a solid platform for rapid growth
Regulatory

Natco Pharma wins US patent case against Teva

Ruling by US Court of Appeals is a major relief to the Indian company
Pharmaceutical

Natco Pharma launches generic sofosbuvir in Nepal

Natco becomes the first Indian company to launch the drug after signing a voluntary licence with Gilead Sciences
Regulatory

Intellectual property battles rage on

Spate of cases filed recently shows that patent battles are heating up
You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical

What future for branded drugs in India?

A landmark patent ruling against Novartis by the Supreme Court in India could lead branded drug manufacturers to review their strategies. Asia correspondent A Nair looks at the implications
Subscribe now